A retrospective observational single center study assessing the real world outcome of Bictegravir/emtricitabine/ tenofovir alafenamide treatment in patients with HIV infection
Latest Information Update: 13 Nov 2020
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 13 Nov 2020 New trial record
- 08 Oct 2020 Results presented at the 15th International Congress on Drug Therapy and HIV Infection